Vaccination against type F botulinum toxin using attenuated Salmonella enterica var Typhimurium strains expressing the BoNT/F HC fragment
Autor: | Jane L. Holley, Susan Foynes, Richard W. Titball, Neil F. Fairweather, Helen S. Garmory |
---|---|
Rok vydání: | 2003 |
Předmět: |
Salmonella typhimurium
Salmonella Botulinum Toxins Genetic Vectors Administration Oral Vaccines Attenuated medicine.disease_cause Microbiology law.invention Mice Bacterial Proteins law Clostridium botulinum Genes Synthetic medicine Animals Botulism Promoter Regions Genetic Heat-Shock Proteins Mice Inbred BALB C Vaccines Synthetic General Veterinary General Immunology and Microbiology biology Serine Endopeptidases Vaccination Public Health Environmental and Occupational Health Membrane Proteins Gene Expression Regulation Bacterial biology.organism_classification medicine.disease Antibodies Bacterial Virology Enterobacteriaceae Botulinum toxin Peptide Fragments Infectious Diseases Salmonella enterica Bacterial Vaccines Recombinant DNA Feasibility Studies Molecular Medicine Female Periplasmic Proteins medicine.drug |
Zdroj: | Vaccine. 21:1052-1059 |
ISSN: | 0264-410X |
DOI: | 10.1016/s0264-410x(02)00622-9 |
Popis: | The utility of the htrA , pagC and nirB promoters to direct the expression of the carboxy-terminal (H C ) fragment of botulinum toxin F (FH C ) in Salmonella enterica var Typhimurium has been evaluated. Only low levels of serum antibody were induced after immunisation, and some protection against botulinum toxin type F was demonstrated after oral immunisation of mice with two doses of any of these recombinant Salmonella . Immunisation with two doses of recombinant Salmonella expressing FH C from the htrA promoter gave the greatest protection, against up to 10,000 mouse lethal doses of botulinum toxin type F. These results demonstrate the feasibility of an orally delivered vaccine against botulinum toxin type F. |
Databáze: | OpenAIRE |
Externí odkaz: |